Chiral Metallohelical Complexes Enantioselectively Target Amyloid Β for Treating Alzheimer’s Disease

Journal of the American Chemical Society - United States
doi 10.1021/ja502789e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Amyloid‐β Oligomers in Cellular Models of Alzheimer’s Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2020English

Alzheimer’s Disease: How Metal Ions Define Β-Amyloid Function

Coordination Chemistry Reviews
Inorganic ChemistryMaterials ChemistryTheoretical ChemistryPhysical
2017English

Β-Amyloid Peptide, Endoplasmic Reticulum Stress, and Alzheimer’s Disease

2012English

Blood Amyloid-Β Oligomerization Associated With Neurodegeneration of Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2019English

Trans-Synaptic Spread of Amyloid-Β in Alzheimer’s Disease: Paths to Β-Amyloidosis

Neural Plasticity
Neurology
2017English

Β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2015English

Simplified Β-Amyloid Peptides for Safer Alzheimer’s Vaccines Development

Human Vaccines
2010English

Microglia Receptors and Their Implications in the Response to Amyloid Β for Alzheimer’s Disease Pathogenesis

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy